These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 79198)

  • 1. Effect of heptabarbital on bioavailability of bishydroxycoumarin in the rat--a critical comment.
    Levy G
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):609-10. PubMed ID: 79198
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of heptabarbital on bioavailability of bishydroxycoumarin in the rat--a reply.
    Feldman S
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):611-2. PubMed ID: 79199
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of heptabarbital on bioavailability of bishydroxycoumarin in the rat.
    Putcha L; Nandiwada P; Feldman S; Bruckner JV; Kramer WG
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):67-74. PubMed ID: 75557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heptabarbital on the response to bishydroxycoumarin in man.
    Aggeler PM; O'Reilly RA
    J Lab Clin Med; 1969 Aug; 74(2):229-38. PubMed ID: 4184022
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of drug action in disease states. XXIX. Effect of experimental nephrotic syndrome on the pharmacodynamics of heptabarbital: implications of severe hypoalbuminemia.
    Hoffman A; Levy G
    J Pharmacol Exp Ther; 1989 Apr; 249(1):117-22. PubMed ID: 2565385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependence of drug plasma level decline in dogs.
    Dayton PG; Cucinell SA; Weiss M; Perel JM
    J Pharmacol Exp Ther; 1967 Nov; 158(2):305-16. PubMed ID: 4169043
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamics and pharmacokinetics of orally administered bishydroxycoumarin in the goat.
    Gross DR; Kramer WG; McCord F; Wagner-Mann C
    Am J Vet Res; 1986 Sep; 47(9):2053-6. PubMed ID: 2429595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lipids on bioavailability of sulfisoxazole acetyl, dicumarol, and griseofulvin in rats.
    Bloedow DC; Hayton WL
    J Pharm Sci; 1976 Mar; 65(3):328-34. PubMed ID: 57233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of coumarin anticoaglulants XLI: Effect of phenobarbital on systemic availability of orally administered dicumarol in rats.
    Crow JW; Gibaldi M; Levy G
    J Pharm Sci; 1979 Aug; 68(8):958-62. PubMed ID: 90143
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative pharmacokinetics of coumarin anticoagulants. VI. Effect of plasma protein binding on the distribution and elimination of bishydroxycoumarin by rats.
    Levy G; Nagashima R
    J Pharm Sci; 1969 Aug; 58(8):1001-4. PubMed ID: 4186544
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative pharmacokinetics of coumarin anticoagulants. II. Pharmacokinetics of bishydroxycoumarin elimination in the rat, guinea pig, dog, and rhesus monkey.
    Nagashima R; Levy G; Back N
    J Pharm Sci; 1968 Jan; 57(1):68-71. PubMed ID: 4172324
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of phenyramidol on the metabolism of bishydroxycoumarin.
    Solomon HM; Schrogie JJ
    J Pharmacol Exp Ther; 1966 Dec; 154(3):660-6. PubMed ID: 4162839
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of phenylbutazone on the distribution, elimination and anticoagulant action of dicumarol in rats.
    Jähnchen E; Wingard LB; Levy G
    J Pharmacol Exp Ther; 1973 Oct; 187(1):176-84. PubMed ID: 4126886
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of salicylate on the fate of bishydroxycoumarin in the rat.
    Thomas BH; Coldwell BB; Buttar HS; Zeitz W
    Can J Physiol Pharmacol; 1973 Mar; 51(3):205-12. PubMed ID: 4122297
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of spironolactone and other steroids on the enzymatic decay and anticoagulant activity of bishydroxycoumarin.
    Solymoss B; Varga S; Krajny M; Werringloer J
    Thromb Diath Haemorrh; 1970 Jun; 23(3):562-8. PubMed ID: 4194159
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of drug action in disease states. V. Acute effect of urea infusion on phenobarbital concentrations in rats at onset of loss of righting reflex.
    Danhof M; Levy G
    J Pharmacol Exp Ther; 1985 Feb; 232(2):430-4. PubMed ID: 2857196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver and fecal bishydroxycoumarin following repeated toxic oral bishydroxycoumarin administration in ground squirrels.
    Colvin HW; Skaife DD; Morrison JT
    Toxicol Appl Pharmacol; 1971 Jun; 19(2):155-63. PubMed ID: 4105823
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative pharmacokinetics of coumarin anticoagulants. 3. Factors affecting the distribution and elimination of bishydroxycoumarin (BHC) in isolated liver perfusion studies.
    Nagashima R; Levy G; Sarcione EJ
    J Pharm Sci; 1968 Nov; 57(11):1881-8. PubMed ID: 4177835
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.
    van der Graaff M; Vermeulen NP; Langendijk PN; Breimer DD
    J Pharmacol Exp Ther; 1983 Jun; 225(3):747-51. PubMed ID: 6134816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of some homologous series of barbiturates in the intact rat and in the isolated perfused rat liver.
    Yih TD; van Rossum JM
    J Pharmacol Exp Ther; 1977 Oct; 203(1):184-92. PubMed ID: 909052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.